Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Geneva Health Forum – Achieving sustainable antibiotic access using a One Health approach

03.05.2022

Time: Tuesday 3 May, 14:00 CET

Every year 1.2 million people die due to drug-resistant infections, more than HIV/AIDS or malaria. The growth of drug-resistant infections is a silent pandemic. If left unchecked, humanity will be unable to treat common illnesses like pneumonia, infections in newborns or secondary bacterial infections caused by viruses. Like COVID-19. Drug-resistant bacteria can infect anyone, of any age, in any country.

Meaningful change can be achieved with sufficient political will, resources and through a holistic One Health approach that embraces efforts to redress the inappropriate use of antimicrobials in humans, animals and environment, all inextricably linked.

Antimicrobial resistance (AMR) is in fact a prime example of the importance of the One Health approach since antibiotic use in any one of these areas can potentially impact the health of the others: AMR fostered by drug use in animals can negatively impact human well-being and vice versa. Additionally, antibiotics administered to both people and animals, and used in agriculture in general, inevitably end up in the environment which can simultaneously impact ecosystem health and potentially become a reservoir for resistant organisms.

Now more than ever, governments have the opportunity to counter the spread of AMR and take action to address the global issue of drug-resistant infections. We know the threat is serious, and we are not preparing well enough.

The objective of this session is to explore how to achieve sustainable antibiotic access using a One Health approach, and leveraging opportunities to support policies, R&D, and implementation to ensure appropriate and equitable access to antibiotics.

Speakers:

  • Jorge Matheu Alvarez, World Health Organization
  • Jennifer Cohn, Global Antibiotic R&D Partnership GARDP
  • Cecilia Ferreyra, FIND
  • Thomas Van Boeckel, ETH Zurich
  • Moderated by: Nadya Wells The Graduate Institute